Cargando…

Thrombosis in Myeloproliferative Neoplasms: A Single Center Experience of Using Whole Blood Platelet Aggregation Studies for Risk Assessment and Thromboprophylaxis

Thromboembolic complications are the most common causes of morbidity and mortality in patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPN); and prevention of these complications remains a significant clinical challenge. Effective thromboprophylaxis in MPN patients genera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manoharan, Arumugam, Gemmell, Rosalie, Cavanaugh, Lauren, Shadood, Noor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340402/ https://www.ncbi.nlm.nih.gov/pubmed/35898172 http://dx.doi.org/10.1177/10760296221117482

Ejemplares similares

A Longitudinal Study of Thrombosis and Bleeding Outcomes With Thromboprophylaxis in Pregnant Women at Intermediate and High Risk of VTE
por: Schapkaitz, E., et al.
Publicado: (2023)

Message in a platelet: decoding platelet transcriptomes in myeloproliferative neoplasms
por: Shapiro, Susan, et al.
Publicado: (2021)

Mechanisms of platelet activation in cancer-associated thrombosis: a focus on myeloproliferative neoplasms
por: Bekendam, Roelof H., et al.
Publicado: (2023)

Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasms
por: Kelliher, Sarah, et al.
Publicado: (2023)

Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
por: Dambrauskienė, Rūta, et al.
Publicado: (2023)

Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
por: Marin Oyarzún, Cecilia P., et al.
Publicado: (2019)

How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?
por: Stanciakova, Lucia, et al.
Publicado: (2022)

Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms
por: Ferrer-Marín, Francisca, et al.
Publicado: (2021)

Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019
por: Mohamed, Adham, et al.
Publicado: (2022)

Increased bleeding and thrombosis in myeloproliferative neoplasms mediated through altered expression of inherited platelet disorder genes
por: Mitchell, Alan, et al.
Publicado: (2023)

Enkurin: A novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens
por: Mosale Seetharam, Sumanth, et al.
Publicado: (2023)

Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens
por: Seetharam, Sumanth Mosale, et al.
Publicado: (2023)

Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018
por: Finazzi, Guido, et al.
Publicado: (2018)

Thrombosis in myeloproliferative neoplasms during cytoreductive and antithrombotic drug treatment
por: Barbui, Tiziano, et al.
Publicado: (2022)

Cerebral venous thrombosis and myeloproliferative neoplasms: A three‐center study of 74 consecutive cases
por: Gangat, Naseema, et al.
Publicado: (2021)

Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression
por: Carnaz Simões, Ana Micaela, et al.
Publicado: (2022)

Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019)

Myeloproliferative neoplasms
por: Kiladjian, Jean-Jacques
Publicado: (2018)

Low Mean Platelet Volume is Associated with Deep Vein Thrombosis in Older Patients with Hip Fracture
por: Wang, Zhicong, et al.
Publicado: (2022)

Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?
por: Koçak Göktürk, Ilgın, et al.
Publicado: (2023)

Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs
por: Liu, Angela, et al.
Publicado: (2022)

Risk of Thrombosis in Myeloproliferative Neoplasms after Sars-Cov-2 Vaccination
por: Borsani, Oscar, et al.
Publicado: (2022)

Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression
por: Simões, Ana Micaela Carnaz, et al.
Publicado: (2022)

Impact of Stereotactic Body Radiotherapy on Thrombin Generation and Platelet Aggregation in Patients with Non-Small Cell Lung Cancer
por: Bentsen, Kristian Kirkelund, et al.
Publicado: (2023)

Epigenetics in Myeloproliferative Neoplasms
por: McPherson, Suzanne, et al.
Publicado: (2017)

Aetiology of Myeloproliferative Neoplasms
por: McMullin, Mary Frances, et al.
Publicado: (2020)

The microenvironment in myeloproliferative neoplasm
por: Méndez-Ferrer, Simón, et al.
Publicado: (2018)

Spleen in myeloproliferative neoplasms
por: Barosi, Giovanni
Publicado: (2018)

Epigenetics in myeloproliferative neoplasms
por: Greenfield, Graeme, et al.
Publicado: (2023)

γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative Neoplasm
por: Görtzen, Jan, et al.
Publicado: (2016)

Patients with myeloproliferative neoplasms and COVID‐19 have increased rates of arterial thrombosis
por: Leiva, Orly, et al.
Publicado: (2022)

The Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Deep Venous Thrombosis: A Systematic Review and Meta-Analysis
por: Hu, Chenming, et al.
Publicado: (2023)

Association Between Platelet Indices and Preoperative Deep Vein Thrombosis in Elderly Patients Undergoing Total Joint Arthroplasty: A Retrospective Study
por: Xiong, Xiaojuan, et al.
Publicado: (2023)

Platelet Aggregation Tests and Thrombosis
por: O'Brien, J. R.
Publicado: (1969)

Platelet Function, Role in Thrombosis, Inflammation, and Consequences in Chronic Myeloproliferative Disorders
por: Repsold, Lisa, et al.
Publicado: (2021)

Gene Expression of CXCL1 (GRO-α) and EGF by Platelets in Myeloproliferative Neoplasms
por: Collinson, Ryan J., et al.
Publicado: (2020)

Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
por: Divoux, Marion, et al.
Publicado: (2020)

Splanchnic vein thrombosis, the onset manifestation in JAK positive Chronic Myeloproliferative Disorders Neoplasms
por: Vladareanu, AM, et al.
Publicado: (2011)

Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists
por: Fedorov, Kateryna, et al.
Publicado: (2021)

Histopathology imagery dataset of Ph-negative myeloproliferative neoplasm
por: Mohamad Yusof, Umi Kalsom, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0msmolkcqvp38tefcp0e8hl1c6